EVE Health Group (ASX: EVE) is an Australian-listed company in the Consumer Defensive sector with a market capitalisation of $5.0M and the 1658th-largest security on the ASX by market capitalisation. The EVE share price is $0.022, up 0.00% today and down 35.29% over the past 12 months. Shares have traded between $0.017 and $0.036 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), EVE Health Group reported revenue of $632,874 and a net loss of $848,470.
About EVE Health Group Limited
Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.
